A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/48 (2006.01) A61K 31/5513 (2006.01) A61K 31/5517 (2006.01)
Patent
CA 2388474
This invention provides novel formulations for N-[4-(5H-pyrrolo[2,1- c][1,4]benzodiazepin-10(11H)ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methyl- benzamide, or a pharmaceutically acceptable salt thereof, and processes for making them, the formulations comprising from about 1 % to about 20 % of active ingredient, from about 1 % to about 18 % of a surfactant component, from about 50 % to about 80 % of a component of one or more polyethylene glycols, from about 1 % to about 20 % of a component of one or more sucrose fatty acid esters and/or polyvinylpyrrolidone and, optionnaly, one or more pharmaceutically acceptable preservatives or antioxidants.
L'invention concerne de nouvelles formulations de N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazépin-10(11H)ylcarbonyl)-3-chlorophényl]-5-fluoro-2-méthyl-benzamide, ou leurs sels pharmaceutiquement acceptables, et leurs procédés de fabrication. Lesdites formulations comprennent environ 1 % à environ 20 % d'un ingrédient actif, environ 1 % à environ 18 % d'un composant tensio-actif, environ 50 % à environ 80 % d'un composant renfermant un ou plusieurs polyéthylèneglycols, environ 1 % à environ 20 % d'un composant renfermant un ou plusieurs esters d'acides gras de sucrose et/ou de polyvinylpyrrolidone et, éventuellement, un ou plusieurs conservateurs ou antioxydants pharmaceutiquement acceptables.
Fawzi Mahdi Bakir
Saunders Richard William
Yoon Joseph Kyuwung
American Cyanamid Company
Ridout & Maybee Llp
LandOfFree
Vasopressin antagonist formulation and process does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vasopressin antagonist formulation and process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vasopressin antagonist formulation and process will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1838651